Curocell Inc.
A clinical-stage biotech developing CAR-T therapies for blood cancers.
372320 | KO
Overview
Corporate Details
- ISIN(s):
- KR7372320002
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 국제과학16로 11, 대전광역시
- Website:
- https://curocellbtx.com/
- Sector:
- Manufacturing
Description
Curocell Inc. is a clinical-stage biotechnology company specializing in the development of Chimeric Antigen Receptor T-cell (CAR-T) therapies. The company focuses on engineering a patient's own immune cells to recognize and eliminate cancer, primarily targeting blood cancers. Curocell's proprietary OVIS™ technology is an immune checkpoint receptor platform designed to enhance the efficacy of CAR-T treatments by overcoming the immunosuppressive tumor microenvironment. The company has advanced its lead candidate, anbalcabtagene autoleucel (Limkato), through Phase 2 clinical trials and operates a state-of-the-art GMP facility for the production of its advanced cell therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-11-15 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-11-13 00:00 |
분기보고서 (2024.09)
|
Korean | 1.3 MB | ||
| 2024-10-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2024-09-26 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2024-08-13 00:00 |
반기보고서 (2024.06)
|
Korean | 974.7 KB | ||
| 2024-05-30 00:00 |
투자판단관련주요경영사항(임상시험결과) (안발셀(CRC01)의 제2상 임상시험내 코호트 2A(림프종) CSR 결과)
|
Korean | 13.8 KB | ||
| 2024-05-14 00:00 |
분기보고서 (2024.03)
|
Korean | 979.2 KB | ||
| 2024-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB | ||
| 2024-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB | ||
| 2024-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.1 KB | ||
| 2024-04-05 00:00 |
주식매수선택권행사
|
Korean | 22.9 KB | ||
| 2024-04-05 00:00 |
전환청구권행사
|
Korean | 8.3 KB | ||
| 2024-03-28 00:00 |
정기주주총회결과
|
Korean | 25.0 KB | ||
| 2024-03-28 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 7.6 KB |
Automate Your Workflow. Get a real-time feed of all Curocell Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Curocell Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Curocell Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
